Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

The likely protocol is to add Brilacidin to Remdesivir as treatment. It would be unethical have an unproven drug go against any standard of care along with a placebo group. Brilacidin has tested as a combination with Remdesivir, so the grouping would be Remdesivir plus B and Remdesivir plus placebo. The R
+ B group would then have an escalation for only B to find optimization. The outcomes would then look for increased efficacy over R alone. Remdesivir has such a low benefit over no treatment that increased benefit is a very low bar.